Efficacy and safety of thyroxine therapy on patients with heart failure and subclinical hypothyroidism: A protocol for systematic review and meta-analysis

BACKGROUND: Subclinical hypothyroidism (SCH) can increase the risk of heart failure (HF) clinically. However, thyroxine therapy for patients with HF and SCH has the risk of developing tachyarrhythmias. At present, there is no sufficient evidence-based medical evidence for levothyroxine in the therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hongshuo, Kan, Zunqi, Liu, Yufan, Li, Wenwen, Peng, Min, Yang, Tiantian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837952/
https://www.ncbi.nlm.nih.gov/pubmed/33545971
http://dx.doi.org/10.1097/MD.0000000000023947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837952/
https://www.ncbi.nlm.nih.gov/pubmed/33545971
http://dx.doi.org/10.1097/MD.0000000000023947

Ejemplares similares